← back to search

Percy Lee

University of California, Los Angeles · US
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Advanced Radiotherapy Techniques, Lung Cancer Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, and Medical Imaging Techniques and Applications.
h-index
46
citations
8,008
works
224
NIH funding
primary concept
Medicine
email

Recent publications

Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative Radiotherapy.
2025cited by 2position: contributordoi
Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial
The Lancet Respiratory Medicine 2024cited by 55position: middledoi
Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors.
2024cited by 5position: contributordoi
Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
2024cited by 2position: contributordoi
Therapeutic Strategies to Target Immunotherapy Resistance in Non-Small Cell Lung Cancer (NSCLC)
2024cited by 0position: contributordoi
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
International Journal of Radiation Oncology*Biology*Physics 2023cited by 116position: middledoi
ICRU REPORT 97: MRI-Guided Radiation Therapy Using MRI-Linear Accelerators
Journal of the ICRU 2022cited by 43position: middledoi
Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
Advances in Radiation Oncology 2022cited by 5position: middledoi
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
Frontiers in Oncology 2021cited by 11position: middledoi
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
International Journal of Radiation Oncology*Biology*Physics 2020cited by 296position: middledoi
The transformation of radiation oncology using real-time magnetic resonance guidance: A review
European Journal of Cancer 2019cited by 180position: middledoi
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities
International Journal of Radiation Oncology*Biology*Physics 2019cited by 93position: middledoi
Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics 2019cited by 62position: firstdoi
Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients
Journal for ImmunoTherapy of Cancer 2019cited by 53position: middledoi
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
Clinical Cancer Research 2018cited by 247position: middledoi
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
Advances in Radiation Oncology 2018cited by 161position: middledoi
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
The Lancet Oncology 2017cited by 1,084position: lastdoi
Online Adaptive Radiation Therapy: Implementation of a New Process of Care
Cureus 2017cited by 119position: lastdoi
Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT
British Journal of Radiology 2017cited by 62position: middledoi
Characterization of spatial distortion in a 0.35 T MRI-guided radiotherapy system
Physics in Medicine and Biology 2017cited by 60position: middledoi
Predicting liver SBRT eligibility and plan quality for VMAT and 4π plans
Radiation Oncology 2017cited by 36position: middledoi
Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference
Practical Radiation Oncology 2017cited by 25position: middledoi
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI‐guided tri‐cobalt 60 radiotherapy system
Medical Physics 2016cited by 119position: middledoi
Multi‐institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors
Cancer 2016cited by 99position: middledoi
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics 2016cited by 90position: middledoi
Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models
Radiotherapy and Oncology 2016cited by 65position: middledoi
Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
Advances in Radiation Oncology 2016cited by 62position: lastdoi
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis
International Journal of Radiation Oncology*Biology*Physics 2016cited by 61position: middledoi
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Clinical Lung Cancer 2015cited by 65position: lastdoi
4π Noncoplanar Stereotactic Body Radiation Therapy for Head-and-Neck Cancer: Potential to Improve Tumor Control and Late Toxicity
International Journal of Radiation Oncology*Biology*Physics 2014cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Minsong Cao · University of California, Los Angeles8 papers (2016–2022)Daniel A. Low · Shell (Canada)8 papers (2012–2017)Patrick A. Kupelian · University of California, Los Angeles6 papers (2012–2015)Ke Sheng · Central South University of Forestry and Technology6 papers (2012–2017)Yingli Yang · University of California, Los Angeles6 papers (2012–2017)Nzhde Agazaryan · University of California, Los Angeles5 papers (2013–2017)James Lamb · University of California, Los Angeles4 papers (2016–2018)Silvia C. Formenti · NYU Langone’s Laura and Isaac Perlmutter Cancer Center4 papers (2017–2019)Narek Shaverdian · MSD K.K. (Japan)4 papers (2015–2018)Amar U. Kishan · University of Colorado Denver4 papers (2017–2022) · 4 papers (2024–2025)X. Allen Li · Medical College of Wisconsin3 papers (2016–2020)Bradley A. Erickson · Arcadis (Czechia)3 papers (2017–2020)David H. Thomas · Thomas Jefferson University3 papers (2016–2017)Christopher L. Hallemeier · Mayo Clinic in Arizona3 papers (2016–2021)Charles B. Simone · Novartis (United States)3 papers (2016–2021)M. Bassetti · University of Wisconsin–Madison3 papers (2017–2019)Dan Nguyen · University of North Texas3 papers (2014–2017)Feng‐Ming Kong · Case Western Reserve University3 papers (2016–2019)Darlene Veruttipong · VA Palo Alto Health Care System3 papers (2015–2017)